• 1
    Jemal A,Siegel R,Ward E,Hao Y,Xu J,Murray T,Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 7196.
  • 2
    McMenamin ME,Soung P,Perera S,Kaplan I,Loda M,Sellers WR. Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage. Cancer Res 1999; 59: 42916.
  • 3
    Aggarwal BB,Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 2006; 71: 1397421.
  • 4
    Pezzuto JM. Plant-derived anticancer agents. Biochem Pharmacol 1997; 53: 12133.
  • 5
    Kong AN,Yu R,Hebbar V,Chen C,Owuor E,Hu R,Ee R,Mandlekar S. Signal transduction events elicited by cancer prevention compounds. Mutat Res 2001; 480–481: 23141.
  • 6
    Ammon HP,Wahl MA. Pharmacology of Curcuma longa. Planta Med 1991; 57: 17.
  • 7
    National Cancer Institute Chemoprevention Branch and Agent Development Committee. Clinical development plan: curcumin. J Cell Biochem 1996; 26S: 7285.
  • 8
    Lin JK,Pan MH,Lin-Shiau SY. Recent studies on the biofunctions and biotransformations of curcumin. Biofactors 2000; 13: 1538.
  • 9
    Dorai T,Cao YC,Dorai B,Buttyan R,Katz AE. Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Prostate 2001; 47: 293303.
  • 10
    Mukhopadhyay A,Bueso-Ramos C,Chatterjee D,Pantazis P,Aggarwal B. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene 2001; 20: 7597609.
  • 11
    Menon LG,Kuttan R,Kuttan G. Anti-metastatic activity of curcumin and catechin. Cancer Lett 1999; 141: 15965.
  • 12
    Papahadjopoulos D,Allen TM,Gabizon A,Mayhew E,Matthay K,Huang SK,Lee KD,Woodle MC,Lasic DD,Redemann C. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci USA 1991; 88: 114604.
  • 13
    Li L,Braiteh FS,Kurzrock R. Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 2005; 104: 132231.
  • 14
    Li L,Ahmed B,Mehta K,Kurzrock R. Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer. Mol Cancer Ther 2007; 6: 127682.
  • 15
    Jang M,Cai L,Udeani GO,Slowing KV,Thomas CF,Beecher CW,Fong HH,Farnsworth NR,Kinghorn AD,Mehta RG,Moon RC,Pezzuto JM. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997; 275: 21820.
  • 16
    Narayanan BA,Re GG,Narayanan NK. Gene expression induced by resveratrol in prostate cancer cells: p53 mediated molecular targets. Int J Cancer 2003; 104: 20412.
  • 17
    Narayanan BA. Chemopreventive agents alters global gene expression pattern: predicting their mode of action and targets. Curr Cancer Drug Targets 2006; 6: 71128.
  • 18
    Steele VE,Kelloff GJ,Balentine D,Boone CW,Mehta R,Bagheri D,Sigman CC,Zhu S,Sharma S. Comparative chemopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro bioassays. Carcinogenesis 2000; 21: 637.
  • 19
    Bhat KP,Pezzuto JM. Cancer chemopreventive activity of resveratrol. Ann N Y Acad Sci 2002; 957: 21029.
  • 20
    Harada N,Murata Y,Yamaji R,Miura T,Inui H,Nakano Y. Resveratrol down-regulates the androgen receptor at the post-translational level in prostate cancer cells. J Nutr Sci Vitaminol (Tokyo) 2007; 53: 55660.
  • 21
    Gill C,Walsh SE,Morrissey C,Fitzpatrick JM,Watson RW. Resveratrol sensitizes androgen independent prostate cancer cells to death-receptor mediated apoptosis through multiple mechanisms. Prostate 2007; 67: 164153.
  • 22
    Harper CE,Patel BB,Wang J,Arabshahi A,Eltoum IA,Lamartiniere CA. Resveratrol suppresses prostate cancer progression in transgenic mice. Carcinogenesis 2007; 28: 194653.
  • 23
    Mann CD,Neal CP,Garcea G,Manson MM,Dennison AR,Berry DP. Phytochemicals as potential chemopreventive and chemotherapeutic agents in hepatocarcinogenesis. Eur J Cancer Prev 2009; 18: 1325.
  • 24
    Cheung KL,Khor TO,Kong AN. Synergistic effect of combination of phenethyl isothiocyanate and sulforaphane or curcumin and sulforaphane in the inhibition of inflammation. Pharm Res 2009; 26: 22431.
  • 25
    Swamy MV,Citineni B,Patlolla JM,Mohammed A,Zhang Y,Rao CV. Prevention and treatment of pancreatic cancer by curcumin in combination with omega-3 fatty acids. Nutr Cancer 2008; 60: 819.
  • 26
    Baur JA,Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 2006; 5: 495506.
  • 27
    Baur JA,Pearson KJ,Price NL,Jamieson HA,Lerin C,Kalra A,Prabhu YV,Allard JS,Lopez-Lluch G,Lewis K,Pistell PJ,Poosala S, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006; 444: 33742.
  • 28
    Walle T,Hsieh F,DeLegge MH,Oatis JE,Jr,Walle UK. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 2004; 32: 137782.
  • 29
    Meng X,Maliakal P,Lu H,Lee MJ,Yang CS. Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice. J Agric Food Chem 2004; 52: 93542.
  • 30
    Ireson CR,Jones DJ,Orr S,Coughtrie MW,Boocock DJ,Williams ML,Farmer PB,Steward WP,Gescher AJ. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev 2002; 11: 10511.
  • 31
    Horn TL,Cwik MJ,Morrissey RL,Kapetanovic I,Crowell JA,Booth TD,McCormick DL. Oncogenicity evaluation of resveratrol in p53(+/−) (p53 knockout) mice. Food Chem Toxicol 2007; 45: 5563.
  • 32
    Ma Z,Shayeganpour A,Brocks DR,Lavasanifar A,Samuel J. High-performance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin. Biomed Chromatogr 2007; 21: 54652.
  • 33
    Wang S,Gao J,Lei Q,Rozengurt N,Pritchard C,Jiao J,Thomas GV,Li G,Roy-Burman P,Nelson PS,Liu X,Wu H. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 2003; 4: 20921.
  • 34
    Lesche R,Groszer M,Gao J,Wang Y,Messing A,Sun H,Liu X,Wu H. Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene. Genesis 2002; 32: 1489.
  • 35
    Wu X,Wu J,Huang J,Powell WC,Zhang J,Matusik RJ,Sangiorgi FO,Maxson RE,Sucov HM,Roy-Burman P. Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation. Mech Dev 2001; 101: 619.
  • 36
    Berquin IM,Min Y,Wu R,Wu J,Perry D,Cline JM,Thomas MJ,Thornburg T,Kulik G,Smith A,Edwards IJ,D'Agostino R, et al. Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids. J Clin Invest 2007; 117: 186675.
  • 37
    Narayanan BA,Narayanan NK,Davis L,Nargi D. RNA interference-mediated cyclooxygenase-2 inhibition prevents prostate cancer cell growth and induces differentiation: modulation of neuronal protein synaptophysin, cyclin D1, and androgen receptor. Mol Cancer Ther 2006; 5: 111725.
  • 38
    Raina K,Singh RP,Agarwal R,Agarwal C. Oral grape seed extract inhibits prostate tumor growth and progression in TRAMP mice. Cancer Res 2007; 67: 597682.
  • 39
    Hahm ER,Arlotti JA,Marynowski SW,Singh SV. Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction. Clin Cancer Res 2008; 14: 124857.
  • 40
    Asensi M,Medina I,Ortega A,Carretero J,Bano MC,Obrador E,Estrela JM. Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radic Biol Med 2002; 33: 38798.
  • 41
    Kawamori T,Lubet R,Steele VE,Kelloff GJ,Kaskey RB,Rao CV,Reddy BS. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res 1999; 59: 597601.
  • 42
    Valentine SP,Le Nedelec MJ,Menzies AR,Scandlyn MJ,Goodin MG,Rosengren RJ. Curcumin modulates drug metabolizing enzymes in the female Swiss Webster mouse. Life Sci 2006; 78: 23918.
  • 43
    Jiao J,Wang S,Qiao R,Vivanco I,Watson PA,Sawyers CL,Wu H. Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development. Cancer Res 2007; 67: 608391.
  • 44
    Narayanan BA,Condon MS,Bosland MC,Reddy BS,Pittman B,Narayanan NK. Suppression of N-methyl-N-nitrosourea (MNU)/testosterone-induced rat prostate cancer growth by celecoxib: effects on COX-2, cell cycle regulation and apoptosis mechanism(s). Clin Cancer Res 2003; 9: 350313.
  • 45
    Miller RG. Simultaneous statistical inference, 2nd edn. New York: Springer-Verlag, 1981; 37 p.
  • 46
    Zeegers MP,Goldbohm RA,van den Brandt PA. Consumption of vegetables and fruits and urothelial cancer incidence: a prospective study. Cancer Epidemiol Biomarkers Prev 2001; 10: 11218.
  • 47
    Nomura AM,Kolonel LN,Hankin JH,Yoshizawa CN. Dietary factors in cancer of the lower urinary tract. Int J Cancer 1991; 48: 199205.
  • 48
    Shankar S,Chen Q,Sarva K,Siddiqui I,Srivastava RK. Curcumin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells: molecular mechanisms of apoptosis, migration and angiogenesis. J Mol Signal 2007; 2: 10.
  • 49
    Narayanan BA,Narayanan NK,Stoner GD,Bullock BP. Interactive gene expression pattern in prostate cancer cells exposed to phenolic antioxidants. Life Sci 2002; 70: 119.
  • 50
    Hong JH,Ahn KS,Bae E,Jeon SS,Choi HY. The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo. Prostate Cancer Prostatic Dis 2006; 9: 14752.
  • 51
    Deeb D,Jiang H,Gao X,Hafner MS,Wong H,Divine G,Chapman RA,Dulchavsky SA,Gautam SC. Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-κB through suppression of IκBα phosphorylation. Mol Cancer Ther 2004; 3: 80312.
  • 52
    Wang TT,Hudson TS,Wang TC,Remsberg CM,Davies NM,Takahashi Y,Kim YS,Seifried H,Vinyard BT,Perkins SN,Hursting SD. Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo. Carcinogenesis 2008; 29: 200110.
  • 53
    Araujo CC,Leon LL. Biological activities of Curcuma longa L. Mem Inst Oswaldo Cruz 2001; 96: 7238.
  • 54
    Barve A,Khor TO,Hao X,Keum YS,Yang CS,Reddy B,Kong AN. Murine prostate cancer inhibition by dietary phytochemicals—curcumin and phenyethylisothiocyanate. Pharm Res 2008; 25: 21819.
  • 55
    Belguendouz L,Fremont L,Linard A. Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins. Biochem Pharmacol 1997; 53: 134755.
  • 56
    Jannin B,Menzel M,Berlot JP,Delmas D,Lançon A,Latruffe N. Transport of resveratrol, a cancer chemopreventive agent, to cellular targets: plasmatic protein binding and cell uptake. Biochem Pharmacol 2004; 68: 111318.